CRISPR Therapeutics AG's ticker is and the CUSIP is 033408113. A total of 1 filers reported holding CRISPR Therapeutics AG in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,088,000 | +20.7% | 20,167 | -34.1% | 0.04% | +2.9% |
| Q3 2020 | $2,559,000 | -2.9% | 30,598 | -14.6% | 0.03% | -8.1% |
| Q2 2020 | $2,635,000 | +68.3% | 35,850 | -2.9% | 0.04% | +42.3% |
| Q1 2020 | $1,566,000 | -33.3% | 36,919 | -4.2% | 0.03% | -13.3% |
| Q4 2019 | $2,347,000 | +47.5% | 38,542 | -0.7% | 0.03% | +36.4% |
| Q3 2019 | $1,591,000 | -13.4% | 38,810 | -0.6% | 0.02% | -15.4% |
| Q2 2019 | $1,838,000 | – | 39,026 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|